Global Immuno-oncology Clinical Trials Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 103

Published Date: 08 Jan 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The growth can be attributed to recent developments in immuno-oncology, changes in lifestyle brought on by urbanization predisposing populations to the rise of cancer, and the growing acceptability of targeted therapy.

According to our (Global Info Research) latest study, the global Immuno-oncology Clinical Trials market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Immuno-oncology Clinical Trials market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Immuno-oncology Clinical Trials market size and forecasts, in consumption value ($ Million), 2018-2029
Global Immuno-oncology Clinical Trials market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Immuno-oncology Clinical Trials market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Immuno-oncology Clinical Trials market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Immuno-oncology Clinical Trials
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Immuno-oncology Clinical Trials market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medpace, Novartis, Exscientia, Syneous Health and AstraZeneca, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Immuno-oncology Clinical Trials market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Phase I
    Phase II
    Phase III
    Phase IV

Market segment by Application
    Solid Tumors
    Hematological Cancer

Market segment by players, this report covers
    Medpace
    Novartis
    Exscientia
    Syneous Health
    AstraZeneca
    ICON plc
    IQVIA Holdings
    BioNtech
    Covance, Inc.
    IO BIOTECH

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Immuno-oncology Clinical Trials product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Immuno-oncology Clinical Trials, with revenue, gross margin and global market share of Immuno-oncology Clinical Trials from 2018 to 2023.
Chapter 3, the Immuno-oncology Clinical Trials competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Immuno-oncology Clinical Trials market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Immuno-oncology Clinical Trials.
Chapter 13, to describe Immuno-oncology Clinical Trials research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Immuno-oncology Clinical Trials
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Immuno-oncology Clinical Trials by Type
        1.3.1 Overview: Global Immuno-oncology Clinical Trials Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Immuno-oncology Clinical Trials Consumption Value Market Share by Type in 2022
        1.3.3 Phase I
        1.3.4 Phase II
        1.3.5 Phase III
        1.3.6 Phase IV
    1.4 Global Immuno-oncology Clinical Trials Market by Application
        1.4.1 Overview: Global Immuno-oncology Clinical Trials Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Solid Tumors
        1.4.3 Hematological Cancer
    1.5 Global Immuno-oncology Clinical Trials Market Size & Forecast
    1.6 Global Immuno-oncology Clinical Trials Market Size and Forecast by Region
        1.6.1 Global Immuno-oncology Clinical Trials Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Immuno-oncology Clinical Trials Market Size by Region, (2018-2029)
        1.6.3 North America Immuno-oncology Clinical Trials Market Size and Prospect (2018-2029)
        1.6.4 Europe Immuno-oncology Clinical Trials Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Immuno-oncology Clinical Trials Market Size and Prospect (2018-2029)
        1.6.6 South America Immuno-oncology Clinical Trials Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Immuno-oncology Clinical Trials Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Medpace
        2.1.1 Medpace Details
        2.1.2 Medpace Major Business
        2.1.3 Medpace Immuno-oncology Clinical Trials Product and Solutions
        2.1.4 Medpace Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Medpace Recent Developments and Future Plans
    2.2 Novartis
        2.2.1 Novartis Details
        2.2.2 Novartis Major Business
        2.2.3 Novartis Immuno-oncology Clinical Trials Product and Solutions
        2.2.4 Novartis Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Novartis Recent Developments and Future Plans
    2.3 Exscientia
        2.3.1 Exscientia Details
        2.3.2 Exscientia Major Business
        2.3.3 Exscientia Immuno-oncology Clinical Trials Product and Solutions
        2.3.4 Exscientia Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Exscientia Recent Developments and Future Plans
    2.4 Syneous Health
        2.4.1 Syneous Health Details
        2.4.2 Syneous Health Major Business
        2.4.3 Syneous Health Immuno-oncology Clinical Trials Product and Solutions
        2.4.4 Syneous Health Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Syneous Health Recent Developments and Future Plans
    2.5 AstraZeneca
        2.5.1 AstraZeneca Details
        2.5.2 AstraZeneca Major Business
        2.5.3 AstraZeneca Immuno-oncology Clinical Trials Product and Solutions
        2.5.4 AstraZeneca Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 AstraZeneca Recent Developments and Future Plans
    2.6 ICON plc
        2.6.1 ICON plc Details
        2.6.2 ICON plc Major Business
        2.6.3 ICON plc Immuno-oncology Clinical Trials Product and Solutions
        2.6.4 ICON plc Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 ICON plc Recent Developments and Future Plans
    2.7 IQVIA Holdings
        2.7.1 IQVIA Holdings Details
        2.7.2 IQVIA Holdings Major Business
        2.7.3 IQVIA Holdings Immuno-oncology Clinical Trials Product and Solutions
        2.7.4 IQVIA Holdings Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 IQVIA Holdings Recent Developments and Future Plans
    2.8 BioNtech
        2.8.1 BioNtech Details
        2.8.2 BioNtech Major Business
        2.8.3 BioNtech Immuno-oncology Clinical Trials Product and Solutions
        2.8.4 BioNtech Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 BioNtech Recent Developments and Future Plans
    2.9 Covance, Inc.
        2.9.1 Covance, Inc. Details
        2.9.2 Covance, Inc. Major Business
        2.9.3 Covance, Inc. Immuno-oncology Clinical Trials Product and Solutions
        2.9.4 Covance, Inc. Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Covance, Inc. Recent Developments and Future Plans
    2.10 IO BIOTECH
        2.10.1 IO BIOTECH Details
        2.10.2 IO BIOTECH Major Business
        2.10.3 IO BIOTECH Immuno-oncology Clinical Trials Product and Solutions
        2.10.4 IO BIOTECH Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 IO BIOTECH Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Immuno-oncology Clinical Trials Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Immuno-oncology Clinical Trials by Company Revenue
        3.2.2 Top 3 Immuno-oncology Clinical Trials Players Market Share in 2022
        3.2.3 Top 6 Immuno-oncology Clinical Trials Players Market Share in 2022
    3.3 Immuno-oncology Clinical Trials Market: Overall Company Footprint Analysis
        3.3.1 Immuno-oncology Clinical Trials Market: Region Footprint
        3.3.2 Immuno-oncology Clinical Trials Market: Company Product Type Footprint
        3.3.3 Immuno-oncology Clinical Trials Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Immuno-oncology Clinical Trials Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Immuno-oncology Clinical Trials Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Immuno-oncology Clinical Trials Consumption Value Market Share by Application (2018-2023)
    5.2 Global Immuno-oncology Clinical Trials Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Immuno-oncology Clinical Trials Consumption Value by Type (2018-2029)
    6.2 North America Immuno-oncology Clinical Trials Consumption Value by Application (2018-2029)
    6.3 North America Immuno-oncology Clinical Trials Market Size by Country
        6.3.1 North America Immuno-oncology Clinical Trials Consumption Value by Country (2018-2029)
        6.3.2 United States Immuno-oncology Clinical Trials Market Size and Forecast (2018-2029)
        6.3.3 Canada Immuno-oncology Clinical Trials Market Size and Forecast (2018-2029)
        6.3.4 Mexico Immuno-oncology Clinical Trials Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Immuno-oncology Clinical Trials Consumption Value by Type (2018-2029)
    7.2 Europe Immuno-oncology Clinical Trials Consumption Value by Application (2018-2029)
    7.3 Europe Immuno-oncology Clinical Trials Market Size by Country
        7.3.1 Europe Immuno-oncology Clinical Trials Consumption Value by Country (2018-2029)
        7.3.2 Germany Immuno-oncology Clinical Trials Market Size and Forecast (2018-2029)
        7.3.3 France Immuno-oncology Clinical Trials Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Immuno-oncology Clinical Trials Market Size and Forecast (2018-2029)
        7.3.5 Russia Immuno-oncology Clinical Trials Market Size and Forecast (2018-2029)
        7.3.6 Italy Immuno-oncology Clinical Trials Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Immuno-oncology Clinical Trials Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Immuno-oncology Clinical Trials Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Immuno-oncology Clinical Trials Market Size by Region
        8.3.1 Asia-Pacific Immuno-oncology Clinical Trials Consumption Value by Region (2018-2029)
        8.3.2 China Immuno-oncology Clinical Trials Market Size and Forecast (2018-2029)
        8.3.3 Japan Immuno-oncology Clinical Trials Market Size and Forecast (2018-2029)
        8.3.4 South Korea Immuno-oncology Clinical Trials Market Size and Forecast (2018-2029)
        8.3.5 India Immuno-oncology Clinical Trials Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Immuno-oncology Clinical Trials Market Size and Forecast (2018-2029)
        8.3.7 Australia Immuno-oncology Clinical Trials Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Immuno-oncology Clinical Trials Consumption Value by Type (2018-2029)
    9.2 South America Immuno-oncology Clinical Trials Consumption Value by Application (2018-2029)
    9.3 South America Immuno-oncology Clinical Trials Market Size by Country
        9.3.1 South America Immuno-oncology Clinical Trials Consumption Value by Country (2018-2029)
        9.3.2 Brazil Immuno-oncology Clinical Trials Market Size and Forecast (2018-2029)
        9.3.3 Argentina Immuno-oncology Clinical Trials Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Immuno-oncology Clinical Trials Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Immuno-oncology Clinical Trials Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Immuno-oncology Clinical Trials Market Size by Country
        10.3.1 Middle East & Africa Immuno-oncology Clinical Trials Consumption Value by Country (2018-2029)
        10.3.2 Turkey Immuno-oncology Clinical Trials Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Immuno-oncology Clinical Trials Market Size and Forecast (2018-2029)
        10.3.4 UAE Immuno-oncology Clinical Trials Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Immuno-oncology Clinical Trials Market Drivers
    11.2 Immuno-oncology Clinical Trials Market Restraints
    11.3 Immuno-oncology Clinical Trials Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Immuno-oncology Clinical Trials Industry Chain
    12.2 Immuno-oncology Clinical Trials Upstream Analysis
    12.3 Immuno-oncology Clinical Trials Midstream Analysis
    12.4 Immuno-oncology Clinical Trials Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Immuno-oncology Clinical Trials Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Immuno-oncology Clinical Trials Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Immuno-oncology Clinical Trials Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Immuno-oncology Clinical Trials Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Medpace Company Information, Head Office, and Major Competitors
    Table 6. Medpace Major Business
    Table 7. Medpace Immuno-oncology Clinical Trials Product and Solutions
    Table 8. Medpace Immuno-oncology Clinical Trials Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Medpace Recent Developments and Future Plans
    Table 10. Novartis Company Information, Head Office, and Major Competitors
    Table 11. Novartis Major Business
    Table 12. Novartis Immuno-oncology Clinical Trials Product and Solutions
    Table 13. Novartis Immuno-oncology Clinical Trials Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Novartis Recent Developments and Future Plans
    Table 15. Exscientia Company Information, Head Office, and Major Competitors
    Table 16. Exscientia Major Business
    Table 17. Exscientia Immuno-oncology Clinical Trials Product and Solutions
    Table 18. Exscientia Immuno-oncology Clinical Trials Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Exscientia Recent Developments and Future Plans
    Table 20. Syneous Health Company Information, Head Office, and Major Competitors
    Table 21. Syneous Health Major Business
    Table 22. Syneous Health Immuno-oncology Clinical Trials Product and Solutions
    Table 23. Syneous Health Immuno-oncology Clinical Trials Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Syneous Health Recent Developments and Future Plans
    Table 25. AstraZeneca Company Information, Head Office, and Major Competitors
    Table 26. AstraZeneca Major Business
    Table 27. AstraZeneca Immuno-oncology Clinical Trials Product and Solutions
    Table 28. AstraZeneca Immuno-oncology Clinical Trials Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. AstraZeneca Recent Developments and Future Plans
    Table 30. ICON plc Company Information, Head Office, and Major Competitors
    Table 31. ICON plc Major Business
    Table 32. ICON plc Immuno-oncology Clinical Trials Product and Solutions
    Table 33. ICON plc Immuno-oncology Clinical Trials Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. ICON plc Recent Developments and Future Plans
    Table 35. IQVIA Holdings Company Information, Head Office, and Major Competitors
    Table 36. IQVIA Holdings Major Business
    Table 37. IQVIA Holdings Immuno-oncology Clinical Trials Product and Solutions
    Table 38. IQVIA Holdings Immuno-oncology Clinical Trials Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. IQVIA Holdings Recent Developments and Future Plans
    Table 40. BioNtech Company Information, Head Office, and Major Competitors
    Table 41. BioNtech Major Business
    Table 42. BioNtech Immuno-oncology Clinical Trials Product and Solutions
    Table 43. BioNtech Immuno-oncology Clinical Trials Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. BioNtech Recent Developments and Future Plans
    Table 45. Covance, Inc. Company Information, Head Office, and Major Competitors
    Table 46. Covance, Inc. Major Business
    Table 47. Covance, Inc. Immuno-oncology Clinical Trials Product and Solutions
    Table 48. Covance, Inc. Immuno-oncology Clinical Trials Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. Covance, Inc. Recent Developments and Future Plans
    Table 50. IO BIOTECH Company Information, Head Office, and Major Competitors
    Table 51. IO BIOTECH Major Business
    Table 52. IO BIOTECH Immuno-oncology Clinical Trials Product and Solutions
    Table 53. IO BIOTECH Immuno-oncology Clinical Trials Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. IO BIOTECH Recent Developments and Future Plans
    Table 55. Global Immuno-oncology Clinical Trials Revenue (USD Million) by Players (2018-2023)
    Table 56. Global Immuno-oncology Clinical Trials Revenue Share by Players (2018-2023)
    Table 57. Breakdown of Immuno-oncology Clinical Trials by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 58. Market Position of Players in Immuno-oncology Clinical Trials, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 59. Head Office of Key Immuno-oncology Clinical Trials Players
    Table 60. Immuno-oncology Clinical Trials Market: Company Product Type Footprint
    Table 61. Immuno-oncology Clinical Trials Market: Company Product Application Footprint
    Table 62. Immuno-oncology Clinical Trials New Market Entrants and Barriers to Market Entry
    Table 63. Immuno-oncology Clinical Trials Mergers, Acquisition, Agreements, and Collaborations
    Table 64. Global Immuno-oncology Clinical Trials Consumption Value (USD Million) by Type (2018-2023)
    Table 65. Global Immuno-oncology Clinical Trials Consumption Value Share by Type (2018-2023)
    Table 66. Global Immuno-oncology Clinical Trials Consumption Value Forecast by Type (2024-2029)
    Table 67. Global Immuno-oncology Clinical Trials Consumption Value by Application (2018-2023)
    Table 68. Global Immuno-oncology Clinical Trials Consumption Value Forecast by Application (2024-2029)
    Table 69. North America Immuno-oncology Clinical Trials Consumption Value by Type (2018-2023) & (USD Million)
    Table 70. North America Immuno-oncology Clinical Trials Consumption Value by Type (2024-2029) & (USD Million)
    Table 71. North America Immuno-oncology Clinical Trials Consumption Value by Application (2018-2023) & (USD Million)
    Table 72. North America Immuno-oncology Clinical Trials Consumption Value by Application (2024-2029) & (USD Million)
    Table 73. North America Immuno-oncology Clinical Trials Consumption Value by Country (2018-2023) & (USD Million)
    Table 74. North America Immuno-oncology Clinical Trials Consumption Value by Country (2024-2029) & (USD Million)
    Table 75. Europe Immuno-oncology Clinical Trials Consumption Value by Type (2018-2023) & (USD Million)
    Table 76. Europe Immuno-oncology Clinical Trials Consumption Value by Type (2024-2029) & (USD Million)
    Table 77. Europe Immuno-oncology Clinical Trials Consumption Value by Application (2018-2023) & (USD Million)
    Table 78. Europe Immuno-oncology Clinical Trials Consumption Value by Application (2024-2029) & (USD Million)
    Table 79. Europe Immuno-oncology Clinical Trials Consumption Value by Country (2018-2023) & (USD Million)
    Table 80. Europe Immuno-oncology Clinical Trials Consumption Value by Country (2024-2029) & (USD Million)
    Table 81. Asia-Pacific Immuno-oncology Clinical Trials Consumption Value by Type (2018-2023) & (USD Million)
    Table 82. Asia-Pacific Immuno-oncology Clinical Trials Consumption Value by Type (2024-2029) & (USD Million)
    Table 83. Asia-Pacific Immuno-oncology Clinical Trials Consumption Value by Application (2018-2023) & (USD Million)
    Table 84. Asia-Pacific Immuno-oncology Clinical Trials Consumption Value by Application (2024-2029) & (USD Million)
    Table 85. Asia-Pacific Immuno-oncology Clinical Trials Consumption Value by Region (2018-2023) & (USD Million)
    Table 86. Asia-Pacific Immuno-oncology Clinical Trials Consumption Value by Region (2024-2029) & (USD Million)
    Table 87. South America Immuno-oncology Clinical Trials Consumption Value by Type (2018-2023) & (USD Million)
    Table 88. South America Immuno-oncology Clinical Trials Consumption Value by Type (2024-2029) & (USD Million)
    Table 89. South America Immuno-oncology Clinical Trials Consumption Value by Application (2018-2023) & (USD Million)
    Table 90. South America Immuno-oncology Clinical Trials Consumption Value by Application (2024-2029) & (USD Million)
    Table 91. South America Immuno-oncology Clinical Trials Consumption Value by Country (2018-2023) & (USD Million)
    Table 92. South America Immuno-oncology Clinical Trials Consumption Value by Country (2024-2029) & (USD Million)
    Table 93. Middle East & Africa Immuno-oncology Clinical Trials Consumption Value by Type (2018-2023) & (USD Million)
    Table 94. Middle East & Africa Immuno-oncology Clinical Trials Consumption Value by Type (2024-2029) & (USD Million)
    Table 95. Middle East & Africa Immuno-oncology Clinical Trials Consumption Value by Application (2018-2023) & (USD Million)
    Table 96. Middle East & Africa Immuno-oncology Clinical Trials Consumption Value by Application (2024-2029) & (USD Million)
    Table 97. Middle East & Africa Immuno-oncology Clinical Trials Consumption Value by Country (2018-2023) & (USD Million)
    Table 98. Middle East & Africa Immuno-oncology Clinical Trials Consumption Value by Country (2024-2029) & (USD Million)
    Table 99. Immuno-oncology Clinical Trials Raw Material
    Table 100. Key Suppliers of Immuno-oncology Clinical Trials Raw Materials
List of Figures
    Figure 1. Immuno-oncology Clinical Trials Picture
    Figure 2. Global Immuno-oncology Clinical Trials Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Immuno-oncology Clinical Trials Consumption Value Market Share by Type in 2022
    Figure 4. Phase I
    Figure 5. Phase II
    Figure 6. Phase III
    Figure 7. Phase IV
    Figure 8. Global Immuno-oncology Clinical Trials Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 9. Immuno-oncology Clinical Trials Consumption Value Market Share by Application in 2022
    Figure 10. Solid Tumors Picture
    Figure 11. Hematological Cancer Picture
    Figure 12. Global Immuno-oncology Clinical Trials Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 13. Global Immuno-oncology Clinical Trials Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 14. Global Market Immuno-oncology Clinical Trials Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 15. Global Immuno-oncology Clinical Trials Consumption Value Market Share by Region (2018-2029)
    Figure 16. Global Immuno-oncology Clinical Trials Consumption Value Market Share by Region in 2022
    Figure 17. North America Immuno-oncology Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 18. Europe Immuno-oncology Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 19. Asia-Pacific Immuno-oncology Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 20. South America Immuno-oncology Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 21. Middle East and Africa Immuno-oncology Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 22. Global Immuno-oncology Clinical Trials Revenue Share by Players in 2022
    Figure 23. Immuno-oncology Clinical Trials Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 24. Global Top 3 Players Immuno-oncology Clinical Trials Market Share in 2022
    Figure 25. Global Top 6 Players Immuno-oncology Clinical Trials Market Share in 2022
    Figure 26. Global Immuno-oncology Clinical Trials Consumption Value Share by Type (2018-2023)
    Figure 27. Global Immuno-oncology Clinical Trials Market Share Forecast by Type (2024-2029)
    Figure 28. Global Immuno-oncology Clinical Trials Consumption Value Share by Application (2018-2023)
    Figure 29. Global Immuno-oncology Clinical Trials Market Share Forecast by Application (2024-2029)
    Figure 30. North America Immuno-oncology Clinical Trials Consumption Value Market Share by Type (2018-2029)
    Figure 31. North America Immuno-oncology Clinical Trials Consumption Value Market Share by Application (2018-2029)
    Figure 32. North America Immuno-oncology Clinical Trials Consumption Value Market Share by Country (2018-2029)
    Figure 33. United States Immuno-oncology Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 34. Canada Immuno-oncology Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 35. Mexico Immuno-oncology Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 36. Europe Immuno-oncology Clinical Trials Consumption Value Market Share by Type (2018-2029)
    Figure 37. Europe Immuno-oncology Clinical Trials Consumption Value Market Share by Application (2018-2029)
    Figure 38. Europe Immuno-oncology Clinical Trials Consumption Value Market Share by Country (2018-2029)
    Figure 39. Germany Immuno-oncology Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 40. France Immuno-oncology Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 41. United Kingdom Immuno-oncology Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 42. Russia Immuno-oncology Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 43. Italy Immuno-oncology Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 44. Asia-Pacific Immuno-oncology Clinical Trials Consumption Value Market Share by Type (2018-2029)
    Figure 45. Asia-Pacific Immuno-oncology Clinical Trials Consumption Value Market Share by Application (2018-2029)
    Figure 46. Asia-Pacific Immuno-oncology Clinical Trials Consumption Value Market Share by Region (2018-2029)
    Figure 47. China Immuno-oncology Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 48. Japan Immuno-oncology Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 49. South Korea Immuno-oncology Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 50. India Immuno-oncology Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 51. Southeast Asia Immuno-oncology Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 52. Australia Immuno-oncology Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 53. South America Immuno-oncology Clinical Trials Consumption Value Market Share by Type (2018-2029)
    Figure 54. South America Immuno-oncology Clinical Trials Consumption Value Market Share by Application (2018-2029)
    Figure 55. South America Immuno-oncology Clinical Trials Consumption Value Market Share by Country (2018-2029)
    Figure 56. Brazil Immuno-oncology Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 57. Argentina Immuno-oncology Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 58. Middle East and Africa Immuno-oncology Clinical Trials Consumption Value Market Share by Type (2018-2029)
    Figure 59. Middle East and Africa Immuno-oncology Clinical Trials Consumption Value Market Share by Application (2018-2029)
    Figure 60. Middle East and Africa Immuno-oncology Clinical Trials Consumption Value Market Share by Country (2018-2029)
    Figure 61. Turkey Immuno-oncology Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 62. Saudi Arabia Immuno-oncology Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 63. UAE Immuno-oncology Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 64. Immuno-oncology Clinical Trials Market Drivers
    Figure 65. Immuno-oncology Clinical Trials Market Restraints
    Figure 66. Immuno-oncology Clinical Trials Market Trends
    Figure 67. Porters Five Forces Analysis
    Figure 68. Manufacturing Cost Structure Analysis of Immuno-oncology Clinical Trials in 2022
    Figure 69. Manufacturing Process Analysis of Immuno-oncology Clinical Trials
    Figure 70. Immuno-oncology Clinical Trials Industrial Chain
    Figure 71. Methodology
    Figure 72. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Medpace
Novartis
Exscientia
Syneous Health
AstraZeneca
ICON plc
IQVIA Holdings
BioNtech
Covance, Inc.
IO BIOTECH

Related Reports

Global Immuno-oncology Clinical Trials Supply, Demand and Key Producers, 2023-2029

Global Immuno-oncology Clinical Trials Supply, Demand and Key Producers, 2023-2029

date 20 Feb 2023

date Medical Care

The global Immuno-oncology Clinical Trials market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Immuno-oncology Clinical Trials Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Immuno-oncology Clinical Trials Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 12 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Immuno-oncology Clinical Trials market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global Immuno-oncology Clinical Trials Supply, Demand and Key Producers, 2024-2030

Global Immuno-oncology Clinical Trials Supply, Demand and Key Producers, 2024-2030

date 14 Feb 2024

date Medical Care

The global Immuno-oncology Clinical Trials market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

Immuno-oncology Clinical Trials

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>